The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

Ozempic (semaglutide) and Wegovy (semaglutide) are prescription drugs that may be used to help with long-term weight loss. But only Wegovy is FDA approved ... Help prevent kidney disease ...

The manufacturer of semaglutide, Novo Nordisk, plans to seek U.S. Food and Drug Administration (FDA) approval for the drug to treat fatty liver disease later this year, researchers said.

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Ozempic (semaglutide) is a medication approved by the Food and Drug Administration (FDA) to treat type 2 diabetes ... medical conditions, such as kidney disease, congestive heart failure ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop ... seek U.S. Food and Drug Administration (FDA) approval for the drug to treat fatty liver disease later this year, researchers said.

THURSDAY, May 1, 2025 (HealthDay News) -- The cutting-edge weight-loss drug Ozempic/Wegovy ... and Drug Administration (FDA) approval for the drug to treat fatty liver disease later this year ...